论文部分内容阅读
晚期前列腺癌目前主要采用睾丸切除和雌激素治疗。缓退瘤(Fugerel 即Flulamide)是一非类固醇类口服的活性雄激素制剂,其对心血管潜伏性、男子乳房女性化、性机能、血凝机制等影响较小,现将我院收治的3例报告如下。病例介绍见附表。讨论美国先灵药厂生产的缓退瘤(Fugerel)是一种非类固醇类纯的雄激素拮抗剂,不抑制促性腺激素的释放。它对晚期前列腺癌的治疗作用与乙烯雌酚相似。从结构上看,Fugerel 是
Advanced prostate cancer is currently mainly treated with orchidectomy and estrogen therapy. Fugerel (Flugel) is a non-steroidal oral administration of active androgenic preparations, which has little effect on cardiovascular latency, feminization of the male breast, sexual function, and hemagglutination mechanism. Now we treat 3 Examples are as follows. Case description see the attached table. DISCUSSION Fugerel, produced by the American drug Schering AG, is a non-steroidal pure androgen antagonist that does not inhibit gonadotropin release. Its treatment of advanced prostate cancer is similar to that of diethylstilbestrol. Structurally, Fugerel is